Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis

Clinical Nuclear Medicine

Volumn 32, Issue 7, 2007, Pages 524-526

  Seldin, David W ^a   Habib, Ihsan ^a   Soudry, Gabriel ^a  

^a Franklin Square Hospital Center ^*  (United States)

Author keywords

F 18 FDG; Pitfalls; Rheumatoid arthritis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; AXILLARY LYMPH NODE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; MEDICAL INFORMATION; POSITRON EMISSION TOMOGRAPHY; RHEUMATOID ARTHRITIS; WHOLE BODY SCINTISCANNING; WRIST;

ARTHRITIS, RHEUMATOID; ARTIFACTS; AXILLA; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC DISEASES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; WHOLE BODY IMAGING;

EID: 34250825996     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318065ba51     Document Type: Article

References (12)

1. Agress H Jr, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417-422.
2. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med. 2005;46:752-757.
3. Israel O, Yefremov N, Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758-762.
4. Rosenbaum SJ, Lind T, Antoch G, et al. False-positive FDG PET uptake - the role of PET/CT. Eur Radiol 2006;16:1054-1065.
5. Palmer WE, Rosenthal DI, Schoenberg OI, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1995;196:647-655.
6. Beckers C, Ribbens C, Andre B, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med. 2004;45:956-964.
7. Bakheet SM, Powe J. Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer. J Nucl Med. 1998;39:234-236.
8. Gupta P, Ponzo F, Kramer EL. Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules. Clin Rheumatol. 2005;24:402-405.
9. Andersson I, Marsal L, Nilsson B, et al. Abnormal axillary lymph nodes in rheumatoid arthritis. Acta Radiol Diagn (Stockh). 1980;21:645-649.
10. Calguneri M, Ozturk MA, Ozbalkan Z, et al. Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus. J Int Med Res. 2003;31:345-349.
11. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61-77.
12. Takamochi K, Yoshida J, Murakami K, et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer. 2005;47:235-242.